Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;77:575-583

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snyders, D. J.
Right arrow Articles by Yeola, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snyders, D. J.
Right arrow Articles by Yeola, S. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*QUINIDINE
*QUINIDINE SULFATE
*QUININE
(Circulation Research. 1995;77:575-583.)
© 1995 American Heart Association, Inc.


Articles

Determinants of Antiarrhythmic Drug Action

Electrostatic and Hydrophobic Components of Block of the Human Cardiac hKv1.5 Channel

Dirk J. Snyders, Sarita W. Yeola

From the Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn.

Abstract The molecular basis of antiarrhythmic drug action is still poorly understood. We recently reported that block of the human cardiac hKv1.5 channel by quinidine displayed similarity with internal quaternary ammonium block of squid and Shaker potassium channels. To gain further insight into the molecular determinants of the affinity and the stereoselectivity of antiarrhythmic drug action, we studied the effects of quinine (a diastereomer of quinidine), clofilium (a quaternary ammonium class III agent), and tetrapentylammonium (TPeA, a biophysical reference probe for the internal quaternary ammonium binding site). For all compounds, block was voltage dependent, with a steep increase over the voltage range of channel opening and a superimposed weaker voltage dependence at more positive potentials. The latter electrostatic component was similar for all drugs, consistent with a binding reaction sensing {approx}20% of the transmembrane electrical field. Clofilium and TPeA displayed a higher apparent affinity (0.15 and 0.28 µmol/L, respectively), and quinine displayed a lower one (21 µmol/L) compared with quinidine (6.2 µmol/L). Block development upon depolarization was time dependent for clofilium and TPeA but slow compared with quinidine. A time-dependent component was difficult to resolve for quinine, but the time course of deactivating tail currents was slower than in the control condition. The resulting crossover phenomenon was also observed for the quaternary drugs. Compared with TPeA alone, the combined application of quinine and TPeA resulted in a reduced current that decayed slower, consistent with competition. When a bimolecular model for open-channel block was used, the apparent association rate constants for these drugs were found to be similar [range, 4.5 to 7.7 (µmol/L)-1 · s-1]. The apparent dissociation rate constants for clofilium (1.9 s-1) and TPeA (3.6 s-1) were smaller compared with quinidine (34 s-1), whereas that for quinine was faster (>=125 s-1). This large range in dissociation rate constants could explain the differences between these drugs both in kinetics and affinity. The results are consistent with a general model in which these agents act as cationic open-channel blockers but with an affinity largely determined by the intrinsic stability of the drug-receptor complex. Hydrophobic interactions are most likely involved in this stabilization of binding.


Key Words: K+ channels • antiarrhythmia agents • quaternary ammonium • quinidine • clofilium




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. M. Schumacher, D. P. McEwen, L. Zhang, K. L. Arendt, K. M. Van Genderen, and J. R. Martens
Antiarrhythmic Drug-Induced Internalization of the Atrial-Specific K+ Channel Kv1.5
Circ. Res., June 19, 2009; 104(12): 1390 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Decher, P. Kumar, T. Gonzalez, B. Pirard, and M. C. Sanguinetti
Binding Site of a Novel Kv1.5 Blocker: A "Foot in the Door" against Atrial Fibrillation
Mol. Pharmacol., October 1, 2006; 70(4): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Decher, P. Kumar, T. Gonzalez, V. Renigunta, and M. C. Sanguinetti
Structural Basis for Competition between Drug Binding and Kv{beta}1.3 Accessory Subunit-Induced N-Type Inactivation of Kv1.5 Channels
Mol. Pharmacol., October 1, 2005; 68(4): 995 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. H. Choi, J.-A. Park, K.-R. Kim, G.-I. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, M.-H. Kim, Y.-H. Seo, and Y.-G. Kwak
Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C425 - C436.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo
Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole
J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. C. Vargas, S. Tenreiro, M. C. Teixeira, A. R. Fernandes, and I. Sa-Correia
Saccharomyces cerevisiae Multidrug Transporter Qdr2p (Yil121wp): Localization and Function as a Quinidine Resistance Determinant
Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2531 - 2537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Decher, B. Pirard, F. Bundis, S. Peukert, K.-H. Baringhaus, A. E. Busch, K. Steinmeyer, and M. C. Sanguinetti
Molecular Basis for Kv1.5 Channel Block: CONSERVATION OF DRUG BINDING SITES AMONG VOLTAGE-GATED K+ CHANNELS
J. Biol. Chem., January 2, 2004; 279(1): 394 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Wang, M. J Morales, Y.-J. Qu, G. C L Bett, H. C Strauss, and R. L Rasmusson
Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect
J. Physiol., January 15, 2003; 546(2): 387 - 401.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Caballero, I. Moreno, T. Gonzalez, C. Valenzuela, J. Tamargo, and E. Delpon
Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5)
Cardiovasc Res, October 1, 2002; 56(1): 104 - 117.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Godreau, R. Vranckx, and S. N. Hatem
Mechanisms of Action of Antiarrhythmic Agent Bertosamil on hKv1.5 Channels and Outward Potassium Current in Human Atrial Myocytes
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 612 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Perchenet, L. Hilfiger, J. Mizrahi, and O. Clement-Chomienne
Effects of Anorexinogen Agents on Cloned Voltage-Gated K+ Channel hKv1.5
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1108 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Iftinca, G. J. Waldron, C. R. Triggle, and W. C. Cole
State-Dependent Block of Rabbit Vascular Smooth Muscle Delayed Rectifier and Kv1.5 Channels by Inhibitors of Cytochrome P450-Dependent Enzymes
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 718 - 728.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
M. W. Brock, C. Mathes, and W. F. Gilly
Selective Open-Channel Block of Shaker (Kv1) Potassium Channels by S-Nitrosodithiothreitol (Sndtt)
J. Gen. Physiol., July 1, 2001; 118(1): 113 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Wang, A. Y. Xiao, T. Ichinose, and S. P. Yu
Effects of Tetraethylammonium Analogs on Apoptosis and Membrane Currents in Cultured Cortical Neurons
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 524 - 530.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
B. H. Choi, J.-S. Choi, S.-W. Jeong, S. J. Hahn, S. H. Yoon, Y.-H. Jo, and M.-S. Kim
Direct Block by Bisindolylmaleimide of Rat Kv1.5 Expressed in Chinese Hamster Ovary Cells
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 634 - 640.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
L. Yue, J. L. Feng, Z. Wang, and S. Nattel
Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes
Cardiovasc Res, April 1, 2000; 46(1): 151 - 161.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Delpon, R. Caballero, C. Valenzuela, M. Longobardo, D. Snyders, and J. Tamargo
Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5)
Cardiovasc Res, May 1, 1999; 42(2): 510 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. L. Cogolludo, F. Perez-Vizcaino, and J. Tamargo
Antagonism by Class I Antiarrhythmic Drugs of Levcromakalim-Induced Relaxation in Isolated Rat Aorta
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 81 - 86.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
Y. Lu, L. Yue, Z. Wang, and S. Nattel
Effects of the Diuretic Agent Indapamide on Na+, Transient Outward, and Delayed Rectifier Currents in Canine Atrial Myocytes
Circ. Res., July 27, 1998; 83(2): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Longobardo, E. Delpón, R. Caballero, J. Tamargo, and C. Valenzuela
Structural Determinants of Potency and Stereoselective Block of hKv1.5 Channels Induced by Local Anesthetics
Mol. Pharmacol., July 1, 1998; 54(1): 162 - 169.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. N. Uebele, S. K. England, D. J. Gallagher, D. J. Snyders, P. B. Bennett, and M. M. Tamkun
Distinct domains of the voltage-gated K+ channel Kvbeta 1.3 beta -subunit affect voltage-dependent gating
Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1485 - C1495.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
F. S.P. Chen and D. Fedida
On the Mechanism by which 4-Aminopyridine Occludes Quinidine Block of the Cardiac K+ Channel, hKv1.5
J. Gen. Physiol., April 1, 1998; 111(4): 539 - 554.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Franqueza, M. Longobardo, J. Vicente, E. Delpon, M. M. Tamkun, J. Tamargo, D. J. Snyders, and C. Valenzuela
Molecular Determinants of Stereoselective Bupivacaine Block of hKv1.5 Channels
Circ. Res., December 19, 1997; 81(6): 1053 - 1064.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Zhang, J. W. Anderson, and D. Fedida

J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1247 - 1256.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Valenzuela, E. Delpon, L. Franqueza, P. Gay, O. Perez, J. Tamargo, and D. J. Snyders
Class III Antiarrhythmic Effects of Zatebradine: Time-, State-, Use-, and Voltage-Dependent Block of hKv1.5 Channels
Circulation, August 1, 1996; 94(3): 562 - 570.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. W. Yeola, T. C. Rich, V. N. Uebele, M. M. Tamkun, and D. J. Snyders
Molecular Analysis of a Binding Site for Quinidine in a Human Cardiac Delayed Rectifier K+ Channel : Role of S6 in Antiarrhythmic Drug Binding
Circ. Res., June 1, 1996; 78(6): 1105 - 1114.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
V. N. Uebele, S. K. England, A. Chaudhary, M. M. Tamkun, and D. J. Snyders
Functional Differences in Kv1.5 Currents Expressed in Mammalian Cell Lines Are Due to the Presence of Endogenous Kvbeta2.1 Subunits
J. Biol. Chem., February 2, 1996; 271(5): 2406 - 2412.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. H. Choi, J.-S. Choi, D.-J. Rhie, S. H. Yoon, D. S. Min, Y.-H. Jo, M.-S. Kim, and S. J. Hahn
Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1461 - C1468.
[Abstract] [Full Text] [PDF]